... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

(Date:6/18/2013)... New York (PRWEB) June 18, 2013 ... dedicated to protecting the rights of victims injured by ... University’s independent review of Medtronic’s Infuse bone graft products ... Internal Medicine, a medical journal, the two studies serve ... difference in effectiveness” when comparing Infuse and the traditional ...

(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...

(Date:6/18/2013)... shown that cancer cells have a much different ... scientists at The University of Texas at Dallas have ... strategy to combat lung cancer. , In an article ... ONE , UT Dallas researchers compared the metabolic characteristics ... taken from the same patient. , They found ...

(Date:6/18/2013)... More than 1.1 million people in the U.S. ages 13 ... for Disease Control and Prevention (CDC). Of those, nearly 20 ... HIV Testing Day on June 27, Allsup, a nationwide provider ... CDC and other organizations are raising awareness of the importance ... new HIV infections each year. Along with developing AIDS, those ...

(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died from respiratory ... of a silicone treatment for gluteus augmentation at Cuerpos Health ... by a mystery Venezuelan doctor in a center that was ... Vazquez of Bayshore Cosmetic Surgery , women suffering from ... not board certified is more common than people think. ...

... Defend Intellectual Property RightsINDIANAPOLIS, March 9 Eli Lilly ... the following statement after being granted a temporary restraining ... of Evista(R) (raloxifene HCl tablets) by Teva Pharmaceuticals. Teva ... version prior to the resolution of outstanding patent litigation ...

... Neogen Corporation (Nasdaq: NEOG ) announced ... common stock repurchase program. In December, Neogen,s Board of ... have been, and additional shares are expected to be, ... depending on market conditions and other factors. Accordingly, there ...

... renders melanomas sensitive to retinoic acid and stops tumor ... cancer therapies such as radiotherapy, chemotherapy, and retinoic acid ... the prognosis for patients is often poor. However, Vincent ... the National Institutes of Health in Bethesda, Maryland, have ...

... Akerman Senterfitt today announced that Julie Gallagher has joined ... Healthcare Practice Group. Ms. Gallagher,s work focuses on ... companies, individual health care providers and health care facilities. ... she spent seven years as a shareholder."We are very ...

... to Announce Fiscal Third Quarter Results on ... Allscripts-Misys Healthcare Solutions, Inc. ("Allscripts") announced today ... to sell its Medication Services business to ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO )The transaction, which is anticipated ...

... Inc. (Nasdaq: KERX ) today announced that ... Listings Qualification Panel ("Panel") the determination of The Nasdaq ... The Nasdaq Capital Market due to noncompliance with Nasdaq ... a minimum of $2,500,000 in stockholders, equity, or $35,000,000 ...

(Date:6/18/2013)... 18, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... announced today that VPII Escrow Corp., a newly formed ... its offer of approximately $3.2 billion aggregate principal amount ... be due in 2021 and in 2023, with final ... to use the net proceeds from the offering, together ...

(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...

(Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... announced public offering of common shares (the "Offering"). Pursuant ... shares at a price of $85.00 per share, for ... will file a final prospectus supplement to its effective ... a similar filing with the securities regulatory authorities in ...